Viewing Study NCT04221451


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-01-02 @ 3:54 PM
Study NCT ID: NCT04221451
Status: TERMINATED
Last Update Posted: 2024-12-30
First Post: 2020-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of Venglustat in Late-onset GM2
Sponsor: Genzyme, a Sanofi Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EFC15299
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators